Aytu Biopharma (AYTU) Capital Expenditures Growth (3y) (2018 - 2024)
Aytu Biopharma (AYTU) Capital Expenditures Growth (3y) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | 6.52% |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn | 232.22% |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | 1.64% |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | 75.58% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | -5.84% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | 32.64% |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | 28.56% |
| 10 | Aytu Biopharma | 22.92 Mn | -3.80 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 26.52% |
| Mar 31, 2020 | 24.17% |
| Dec 31, 2019 | 128.22% |
| Jun 30, 2019 | -19.27% |
| Mar 31, 2019 | -30.06% |
| Dec 31, 2018 | 13.71% |